Sun: Manitoba researcher leads Alzheimer’s clinical trial
Manitoba researchers are leading the charge in a clinical trial of a new treatment for Alzheimer’s disease.
Dr. Zahra Moussavi, from the University of Manitoba’s engineering faculty, received $1.738 million Tuesday from the Weston Brain Institute for her project on investigating treatment for the disease, which has no known cure. Moussavi’s study will build on other trials that measure the effects of repetitive transcranial magnetic stimulation (rTMS) in Alzheimer’s patients, with Moussavi’s work representing the first large placebo-controlled double-blind study designed with sufficient statistical rigor to get a better gauge on its efficacy.
“I am optimistic that rTMS treatment can help to slow the progression of the disease if applied at early and moderate stages,” said Moussavi, in a press release.